FoodCAP: acid-labile protein adducts of heterocyclic amines in human blood are not viable biomarkers of HCA dietary exposure

Intake of heterocyclic amines (HCAs, carcinogens produced during cooking of meat/fish, the most abundant being PhIP, DiMeIQx and MeIQx) is influenced by many factors including type/thickness of meat and cooking method/temperature/duration. Thus, assessment of HCA dietary exposure is difficult. Protein adducts of HCAs have been proposed as potential medium-term biomarkers of exposure, e.g. PhIP adducted to serum albumin or haemoglobin. However, evidence is still lacking that HCA adducts are viable biomarkers in humans consuming normal diets. The FoodCAP project, supported by World Cancer Research Fund, developed a highly sensitive mass spectrometric method for hydrolysis, extraction and detection of acid-labile HCAs in blood and assessed their validity as biomarkers of exposure. Multiple acid/alkaline hydrolysis conditions were assessed, followed by liquid-liquid extraction, clean-up by cation-exchange SPE and quantification by UPLC-ESI-MS/ MS. Blood was analysed from volunteers who completed food diaries to estimate HCA intake based on the US National Cancer Institute’s CHARRED database. Standard HCAs were recovered quantitatively from fortified blood. In addition, PhIP/MeIQx adducts bound to albumin and haemoglobin prepared in vitro using a human liver microsome system were also detectable in blood fortified at low ppt concentrations. However, except for one sample (5pg/ml PhIP), acid-labile PhIP, 7,8-DiMeIQx, 4,8-DiMeIQx and MeIQx were not observed above the 2pg/ml limit of detection in plasma (n=35), or in serum, whole blood or purified albumin, even in volunteers with high meat consumption (nominal HCA intake >2µg/day). It is concluded that HCA blood protein adducts are not viable biomarkers of exposure. Untargeted metabolomic analyses may facilitate discovery of suitable markers.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Background: Ataluren was developed to restore functional protein production in genetic disorders caused by nonsense mutations, which are the cause of cystic fibrosis in 10% of patients. This trial was designed to assess the efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis. 

Methods: This randomised, double-blind, placebo-controlled, phase 3 study enrolled patients from 36 sites in 11 countries in North America and Europe. Eligible patients with nonsense-mutation cystic fibrosis (aged ≥6 years; abnormal nasal potential difference; sweat chloride >40 mmol/L; forced expiratory volume in 1 s [FEV₁] ≥40% and ≤90%) were randomly assigned by interactive response technology to receive oral ataluren (10 mg/kg in morning, 10 mg/kg midday, and 20 mg/kg in evening) or matching placebo for 48 weeks. Randomisation used a block size of four, stratified by age, chronic inhaled antibiotic use, and percent-predicted FEV₁. The primary endpoint was relative change in percent-predicted FEV₁ from baseline to week 48, analysed in all patients with a post-baseline spirometry measurement. This study is registered with ClinicalTrials.gov, number NCT00803205. 

Findings: Between Sept 8, 2009, and Nov 30, 2010, 238 patients were randomly assigned, of whom 116 in each treatment group had a valid post-baseline spirometry measurement. Relative change from baseline in percent-predicted FEV₁ did not differ significantly between ataluren and placebo at week 48 (-2·5% vs -5·5%; difference 3·0% [95% CI -0·8 to 6·3]; p=0·12). The number of pulmonary exacerbations did not differ significantly between treatment groups (rate ratio 0·77 [95% CI 0·57-1·05]; p=0·0992). However, post-hoc analysis of the subgroup of patients not using chronic inhaled tobramycin showed a 5·7% difference (95% CI 1·5-10·1) in relative change from baseline in percent-predicted FEV₁ between the ataluren and placebo groups at week 48 (-0·7% [-4·0 to 2·1] vs -6·4% [-9·8 to -3·7]; nominal p=0·0082), and fewer pulmonary exacerbations in the ataluern group (1·42 events [0·9-1·9] vs 2·18 events [1·6-2·7]; rate ratio 0·60 [0·42-0·86]; nominal p=0·0061). Safety profiles were generally similar for ataluren and placebo, except for the occurrence of increased creatinine concentrations (ie, acute kidney injury), which occurred in 18 (15%) of 118 patients in the ataluren group compared with one (<1%) of 120 patients in the placebo group. No life-threatening adverse events or deaths were reported in either group. I

nterpretation: Although ataluren did not improve lung function in the overall population of nonsense-mutation cystic fibrosis patients who received this treatment, it might be beneficial for patients not taking chronic inhaled tobramycin. 

Funding: PTC Therapeutics, Cystic Fibrosis Foundation, US Food and Drug Administration's Office of Orphan Products Development, and the National Institutes of Health. 

Characterisation of a two-dimensional liquid-filled ion chamber detector array using flattened and unflattened beams for small fields, small MUs and high dose-rates

In this study, the PTW 1000SRS array with Octavius 4D phantom was characterised for FF and FFF beams. MU linearity, field size, dose rate, dose per pulse (DPP) response and dynamic conformal arc treatment accuracy of the 1000SRS array were assessed for 6MV, 6FFF and 10FFF beams using a Varian TrueBeam STx linac. The measurements were compared with a pinpoint IC, microdiamond IC and EBT3 Gafchromic film. Measured dose profiles and FWHMs were compared with film measurements. Verification of FFF volumetric modulated arc therapy (VMAT) clinical plans were assessed using gamma analysis with 3%/3 mm and 2%/2 mm tolerances (10% threshold). To assess the effect of cross calibration dose rate, clinical plans with different dose rates were delivered and analysed. Output factors agreed with film measurements to within 4.5% for fields between 0.5 and 1 cm and within 2.7% for field sizes between 1.5 and 10 cm and were highly correlated with the microdiamond IC detector. Field sizes measured with the 1000SRS array were within 0.5 mm of film measurements. A drop in response of up to 1.8%, 2.4% and 5.2% for 6MV, 6FFF and 10FFF beams respectively was observed with increasing nominal dose rate. With an increase in DPP, a drop of up to 1.7%, 2.4% and 4.2% was observed in 6MV, 6FFF and 10FFF respectively. The differences in dose following dynamic conformal arc deliveries were less than 1% (all energies) from calculated. Delivered VMAT plans showed an average pass percentage of 99.5(±0.8)% and 98.4(±3.4)% with 2%/2 mm criteria for 6FFF and 10FFF respectively. A drop to 97.7(±2.2)% and 88.4(±9.6)% were observed for 6FFF and 10FFF respectively when plans were delivered at the minimum dose rate and calibrated at the maximum dose rate. Calibration using a beam with the average dose rate of the plan may be an efficient method to overcome the dose rate effects observed by the 1000SRS array.

Estudio de factibilidad para la creación de una estación de servicio para la Compañía de transporte urbano DISUTRAN S.A. en el sur de Quito

En el capítulo I se encuentra el Estudio de Mercado, que a su vez describe temas como: objetivos del estudio de mercado identificación de los servicios y productos, identificación del consumidor, ingresos del consumidor, determinación dela muestra, procesamiento y análisis de las encuestas, determinación de la demanda, determinación de la oferta, proyección de la demanda y estrategias de Michael E. Porter. El capítulo II Estudio Técnico del Proyecto describe la localización macro y micro del proyecto, su ingeniería, base legal, organización de la empresa que incluye la organización estructural, clasificación de puestos de trabajo por niveles de gestión, organización funcional y organización por procesos. En el capítulo III se describe el Estudio financiero, el mismo que contiene las inversiones, el análisis financiero y la evaluación financiera. El capítulo IV se refiere a los Indicadores Financieros: razones de liquidez, de operación, de endeudamiento y de rentabilidad. Finalmente en el capítulo V se anotan las conclusiones y recomendaciones que se establecieron en base al trabajo de campo realizado, así como también se anota la bibliografía utilizada en el desarrollo de la investigación junto con los anexos respectivos.

Estudio y análisis de eficiencia de un quemador de fuel oil N. 6, con calentamiento del aire de pulverización para un caldero de 300 BPH

La presente tesis está enfocada al análisis estrictamente de la combustión de un quemador de aceite (fuel oil # 6) para un caldero degeneración de vapor de agua de 300 BHP de potencia, el cual para su atomización del combustible usa aire comprimido a 40 PSI de presión y una temperatura que va desde los 15 ºC hasta los 150 ºC según nuestra particular implementación del sistema de calentamiento. El desarrollo emprende desde un marco teórico de los quemadores, sus partes consistentes, el combustible, clasificación, propiedades y características. De manera muy particular nos centramos en el proceso de combustión por cuanto es la parte medular del presente documento, así como generalidades, fundamentos, los elementos y productos, los comportamientos de éstos en la combustión. Además enfocamos conceptos básicos de tipos de combustión. En una forma analítica se establece la ecuación general de la combustión, una evaluación de la energía liberada en el proceso, en base al volumen y composición de lso productos que intervienne en la misma, yademás de la forma de cómo calibrar el equipo o sistema para obtener combustion lo más eficiente posible, sea produciendo energía calorífica más alta posible con el mínimo requerido posible de combustión. Se enfoca en el presente documento un análisis de las relaciones termodinámicas en la combustión como: la entalpía de los elementos como de los productos, las entalpías de formación de los mismos, le energía interna de los gases productos, y de la entropía o irreversibilidades del proceso total de combustión. La determinación del calor generado más la temperatura de llama adiabática son temas fundamentales en el desarrollo del tema, es por lo tanto parte importante del documento. Ya en el análisis experimental se parte del hecho de tener instalado a modo de prueba un intercambiador de calor para calentar el aire de atomización en uncaldero específico, esto es en un caldero de 300 BHP de potencia, de generación de vapor de agua de 100 PSI de presión, en la empresa Tejidos Pintex, y el análisis va enfocado a determinar la efectividad o no de calentar el aire de atomización, y de ser así cuantificar los beneficios del sistema.

Responsabilidade e governação na moderna gestão hospitalar

Esta dissertação, elaborada com vista à obtenção do grau de doutor pela Universidade de Aveiro, compõe-se de onze capítulos. O primeiro inclui, além de uma introdução, a justificação, os objectivos e a estrutura da dissertação. Seguem-se quatro capítulos relativos às empresas privadas onde são abordados, sucessivamente, as teorias da governação, a governação e gestão nas empresas, a regulação e a avaliação da performance, a avaliação da governação e da gestão de topo. O capítulo VI é dedicado à produção e avaliação na Administração Pública seguindo-se dois capítulos, um abordando a especificidade dos hospitais e da sua avaliação o outro caracterizando o hospital público português e a sua avaliação. No capítulo IX faz-se a síntese do que pode ser designado enquadramento teórico. No estudo empírico, capítulo X, definimos o problema, “Inexistência de modelo de avaliação dos conselhos de administração (CA) dos hospitais entidade pública empresarial”, descrevemos a metodologia seguida e os resultados obtidos, que se traduzem num modelo de avaliação dos CA. O modelo é constituído por três áreas – Resultados do hospital, Cumprimento da estratégia, Forma como o CA actuou e liderou – decompostas em critérios e indicadores, adequadamente ponderados, que permitem a valoração concreta de um qualquer CA de hospital EPE. Este modelo recolheu um consenso elevado dos principais peritos nacionais no tema que participaram nas técnicas de consenso usadas para a sua construção: um painel Delphi e três Técnicas de Grupo Nominal. Finalmente no capítulo XI extraímos as conclusões e referimos questões para investigação futura.